SCHEMBL8091952

SCHEMBL8091952

CCCCCS(=O)(=O)NC(=O)NS(=O)(=O)CCCCC

nearest known ligand 0.53

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.43
EPHX2 P34913 1/20 0.42
EPHX1 P07099 2/20 0.41
PTPN1 P18031 1/20 0.40
CES2 O00748 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13113281 0.84 FAAH (0.41) FAAHPTPN1CES2
SCHEMBL3220018 0.84 PTPN1 (0.43) FAAHPTPN1CES2
SCHEMBL19630951 0.83 HPGD (0.35) EPHX1PTPN1
SCHEMBL13671233 0.83 FAAH (0.45) FAAHPTPN1CES2
SCHEMBL4668386 0.83 FAAH (0.45) FAAHPTPN1CES2
SCHEMBL4666760 0.83 FAAH (0.45) FAAHPTPN1CES2
SCHEMBL4602875 0.83 FAAH (0.40) FAAHPTPN1CES2
SCHEMBL4296201 0.83 FAAH (0.45) FAAHPTPN1CES2
SCHEMBL1347954 0.83 RELA (0.41) FAAH
SCHEMBL11500930 0.83 FAAH (0.40) FAAHPTPN1CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6147115-A SULFONYLUREIDO-4-HALOBENZENE DERIVATIVES; ANTICARCINOGENIC AGENTS ELI LILLY AND COMPANY (US) 2000-11-14 US disclosed
EP-0550157-B1 Antitumor compositions and methods of treatment LILLY CO ELI (US) 1997-07-23 EP disclosed
US-5354778-A N-Phenyl-N'-substituted phenylsulfonylureas ELI LILLY AND COMPANY (US) 1994-10-11 US disclosed
EP-0467621-B1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them LILLY CO ELI (US) 1994-06-15 EP disclosed
US-5234955-A N-phenyl-N*-substituted phenylsulfonylureas ELI LILLY AND COMPANY (US) 1993-08-10 US disclosed
EP-0550157-A1 Antitumor compositions and methods of treatment ELI LILLY AND COMPANY (US) 1993-07-07 EP disclosed
US-5216026-A Administering to the mammal N-1-butanesulfonamide derivatives and salts ELI LILLY AND COMPANY (US) 1993-06-01 US disclosed
EP-0467621-A1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them ELI LILLY AND COMPANY (US) 1992-01-22 EP disclosed